StocksMedium•12 November 2026•
1 min read
Prime Medicine Reports Narrower-Than-Expected Q3 Loss
Key Facts
1Prime Medicine reported a quarterly loss of $0.22 per share, narrower than the Zacks Consensus Estimate of a $0.23 loss.
2The current quarter's results represent an improvement compared to a loss of $0.32 per share a year ago.
Prime Medicine reported a quarterly loss of $0.22 per share for the third quarter of 2026. Zacks reported that these results were narrower than the analyst consensus estimate, which had projected a loss of $0.23 per share.
The current quarter's results represent an improvement from the $0.32 per share loss recorded in the same quarter a year ago. PRME closed at $4.3 on November 11, 2026, with the stock trading between a low of $3.8 and a high of $4.35 during that session.